Accession	Type	Description
PXD005336	LFQ	Clinical Kinase Inhibitors
PXD013615	LFQ	ATLANTIC: Activity landscapes of tumor cell lines determine drug responses
PXD029009	DIA	A proteomic survival predictor for COVID-19 patients in intensive care
PXD015087	TMT/LFQ	High-flow chromatography for reproducible and high-throughput quantification of proteomes
PXD020191	TMT	Human Lung cancer proteomics and proteogenomics LC/MS&MS
